Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chun-Dong Gu"'
Autor:
Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, Chun Chen, Chun-Dong Gu, Jun Wang, Xue-Ning Yang, Wei-Min Mao, Qun Wang, Gui-Bin Qiao, Ying Cheng, Lin Xu, Chang-Li Wang, Ming-Wei Chen, Xiao-Zheng Kang, Wan-Pu Yan, Ri-Qiang Liao, Jin-Ji Yang, Xu-Chao Zhang, Si-Yang Liu, Qing Zhou, Yi-Long Wu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-8 (2023)
Abstract EMERGING-CTONG 1103 showed improved progression-free survival (PFS) with neoadjuvant erlotinib vs. chemotherapy for patients harbouring EGFR sensibility mutations and R0 resected stage IIIA-N2 non-small cell lung cancer (NSCLC) (NCT01407822)
Externí odkaz:
https://doaj.org/article/1f184cb431924c6cb798d962d9892a83
Autor:
Lin Xu, Xiaozheng Kang, Qun Wang, Hong-Hong Yan, Gui-bin Qiao, Weimin Mao, Changli Wang, Jin-Ji Yang, Ri-Qiang Liao, Chun-Dong Gu, Yi-Long Wu, Ke-Neng Chen, Wen-Zhao Zhong, Xu-Chao Zhang, Jun Wang, Mingwei Chen, Qing Zhou, Wanpu Yan, Chun Chen, Ying Cheng, Xue-Ning Yang
Publikováno v:
Journal of Clinical Oncology. 37:2235-2245
PURPOSE To assess the benefits of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as neoadjuvant/adjuvant therapies in locally advanced EGFR mutation-positive non–small-cell lung cancer. PATIENTS AND METHODS This was a multicente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84962b23ce4d83302ffcf72ea71472ff
https://doi.org/10.1200/jco.19.00075
https://doi.org/10.1200/jco.19.00075
Autor:
Wen-Zhao, Zhong, Ke-Neng, Chen, Chun, Chen, Chun-Dong, Gu, Jun, Wang, Xue-Ning, Yang, Wei-Min, Mao, Qun, Wang, Gui-Bin, Qiao, Ying, Cheng, Lin, Xu, Chang-Li, Wang, Ming-Wei, Chen, Xiaozheng, Kang, Wanpu, Yan, Hong-Hong, Yan, Ri-Qiang, Liao, Jin-Ji, Yang, Xu-Chao, Zhang, Qing, Zhou, Yi-Long, Wu
Publikováno v:
Translational Cancer Research
To assess the benefits of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as neoadjuvant/adjuvant therapies in locally advancedThis was a multicenter (17 centers in China), open-label, phase II, randomized controlled trial of erlot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5468dddb8e31c886171ce8015fb8970
https://pubmed.ncbi.nlm.nih.gov/35117147
https://pubmed.ncbi.nlm.nih.gov/35117147
Autor:
Chun Chen, Chun-Dong Gu, Xu-Chao Zhang, Weimin Mao, Changli Wang, Ri-Qiang Liao, Lin Xu, Yi-Long Wu, Ying Cheng, Fan Yang, Si-Yang Liu, Qing Zhou, Hong-Hong Yan, Qun Wang, Mingwei Chen, Xue-Ning Yang, Gui-Bin Qiao, Wen-Zhao Zhong, Jin-Ji Yang, Ke-Neng Chen
Publikováno v:
Journal of Clinical Oncology. 39:8502-8502
8502 Background: Median Overall survival (mOS) of stage IIIA resected NSCLC was 59.4 months (m) in CTONG 1104 adj gefitinib and 26.2m in SAKK neoadjuvant chemo trial. EMERGING-CTONG1103 showed neo-adjuvant/adjuvant erlotinib treatment significantly i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f86c746e595d14c0cc126613c02218ee
https://doi.org/10.1200/jco.2021.39.15_suppl.8502
https://doi.org/10.1200/jco.2021.39.15_suppl.8502
Autor:
Jiu-Wei Cui, Lei Xiong, Ying Cheng, Zhiyong Ma, Li Zhang, Caicun Zhou, Qun Wang, Qi-Bin Song, Xiaoqing Liu, Jian Zhao, Shao-Kun Chuai, Guanshan Zhu, Ming Chen, You Lu, Shiying Yu, Yi-Long Wu, Gang Chen, Shenglin Ma, Yong Song, Helong Zhang, Yang Shen-Tu, Ming‐fang Zhao, Zhi-Min Yang, Junling Li, Xue-Ning Yang, Jin-Ji Yang, Jie Hu, Gongyan Chen, Guangying Zhu, Baohui Han, Wei He, Ding Yu, Ke-Neng Chen, Fan Yang, Xu-Chao Zhang, Wen-Zhao Zhong, Jifeng Feng, Yang Shao, Lin Xu, Jun Liang, Yi Hu, Yun Fan, Chun-Dong Gu, Qing Zhou, Qinghua Zhou, Zhong-Zhen Guan, Weimin Mao, Changli Wang, Shun Lu, Qiong Zhao, Meilin Liao, Yue Yang, Gui-bin Qiao, Yan Sun, Yi-Chen Zhang, Jian Jun Wang, Jianhua Chang, Jie Wang
Publikováno v:
ESMO Open
The diagnosis and treatment of lung cancer have evolved into the era of precision medicine. Liquid biopsy, a minimally invasive approach, has emerged as a promising practice in genetic profiling and monitoring of lung cancer. Translating liquid biops
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c74d545ecd8615e4ade081019bad1d
http://europepmc.org/articles/PMC5559904
http://europepmc.org/articles/PMC5559904
Autor:
Qianli Wang, Mingwei Chen, Weimin Mao, Changli Wang, K.-N. Chen, G.-B. Qiao, J.-J. Yang, Wen-Zhao Zhong, Lei Xu, X.-N. Yang, Yung-Chi Cheng, H.-H. Yang, Qing Zhou, H. Chen, Chuanben Chen, Y-L. Wu, Junpei Wang, Chun-Dong Gu
Publikováno v:
Annals of Oncology. 29:viii738
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ccfb27ed197c8dd0200bf3b2d095828
https://doi.org/10.1093/annonc/mdy424.058
https://doi.org/10.1093/annonc/mdy424.058
Autor:
Shi-lei, Zhao, Chun-dong, Gu
Publikováno v:
Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns. 29(5)
Caustic esophageal burn is a common ailment in clinical practice. In some patients, scar stricture was formed in the late stage of injury, and it seriously undermined quality of life of the patients. We adopted various clinical interventions at an ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9463dc017a7a1100a20f8958f359694
https://pubmed.ncbi.nlm.nih.gov/24360005
https://pubmed.ncbi.nlm.nih.gov/24360005